- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Mayo Clinic](/img/noimage_org.png)
Mayo Clinic
Rochester, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Mayo Clinic (9)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Database, Vol. 2019, pp. 1-67
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences
Journal of the American College of Cardiology, Vol. 69, Núm. 7, pp. 841-858
2012
-
GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution
Gene Therapy, Vol. 19, Núm. 11, pp. 1048-1057
2006
2005
-
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors
Laboratory Investigation, Vol. 85, Núm. 9, pp. 1065-1075
2004
-
Initial immunoglobulin M 'Flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: An Eastern Cooperative Oncology Group Study
Cancer, Vol. 101, Núm. 11, pp. 2593-2598
-
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)
Leukemia and Lymphoma, Vol. 45, Núm. 10, pp. 2047-2055